Cyclo Therapeutics, Inc. (CYTH) Financials
CYTH Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 13.2 million | 8.5 million |
| 2023-09-30 | 5.6 million | 6.6 million |
| 2023-06-30 | 4.6 million | 6.1 million |
| 2023-03-31 | 4.1 million | 4.5 million |
CYTH Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -4.3 million | 257771 |
| 2023-09-30 | -4.0 million | 202040 |
| 2023-06-30 | -3.5 million | 185436 |
| 2023-03-31 | -4.4 million | 91668 |
CYTH Net Income
No data available :(
CYTH Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 9.2 million | - | 1.0 million |
| 2023-09-30 | 1.8 million | - | 45232 |
| 2023-06-30 | 841530 | - | 49405 |
| 2023-03-31 | 915176 | - | 53496 |
CYTH Shares Outstanding
CYTH Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 2420 | 4.1 million | 1.4 million | 1383 |
| 2023-09-30 | - | 3.5 million | 1.5 million | 1297 |
| 2023-06-30 | - | 3.2 million | 1.3 million | 403 |
| 2023-03-31 | - | 3.4 million | 1.7 million | 819 |
CYTH Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 311399 | 876552 |
| 2023-09-30 | 495477 | 38767 |
| 2023-06-30 | 117118 | 19909 |
| 2023-03-31 | 152411 | 10196 |
CYTH
Price: $1.47
52 week price:
Earnings Per Share: -1.23 USD
P/E Ratio: -1.12
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 140400
Market Capitalization: 39.3 million